Examples of using Laboratory monitoring in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
Clinical and laboratory monitoring for hyperbilirubinaemia is recommended.
Includes observations collected as part of routine laboratory monitoring.
Increased clinical and laboratory monitoring are warranted see section 4.4.
Frequency category derived from laboratory values collected as part of routine laboratory monitoring in clinical trials.
For laboratory monitoring of pregnancy, please refer to Laboratory tests.
were identified early through clinical and laboratory monitoring, and had a positive outcome after treatment.
Close clinical and laboratory monitoring is recommended when giving digoxin concomitantly with Possia see section 4.5.
It is impossible to imagine a modern pharmaceutical production without equipped laboratory monitoring of incoming raw materials
with increased clinical and laboratory monitoring.
For clinical or laboratory monitoring regarding immunocompromised individuals
in patients without a functional CYP2C19 allele, close clinical and laboratory monitoring of voriconazole-associated adverse events is recommended.
During routine laboratory monitoring in the tocilizumab all exposure population, a decrease in neutrophil count below 1× 109/L occurred in 3.7% of patients.
with increased clinical and laboratory monitoring.
Appropriate clinical and/or laboratory monitoring is recommended for patients receiving concomitant metformin
ECG and/or laboratory monitoring is recommended for patients receiving concomitant digoxin
Therefore, appropriate clinical and/or laboratory monitoring is recommended when giving narrow therapeutic index P-gp dependent medicinal products like digoxin concomitantly with ticagrelor.
During routine laboratory monitoring in the tocilizumab all exposure population, 1% of patients had a decrease in platelet
Regular clinical and laboratory monitoring for CMV infection is recommended in patients with positive CMV serology at the start of treatment with idelalisib or with other evidence of a history of CMV infection.
Therefore, appropriate clinical and/or laboratory monitoring is recommended when giving narrow therapeutic index P-gp dependent medicinal products like digoxin
During routine laboratory monitoring in the 12 week controlled phase, 3% of patients in the placebo group
During routine laboratory monitoring in the 12 week controlled phase, elevation in ALT or AST≥ 3 x ULN occurred in 5% and 3% of patients, respectively, in the tocilizumab group, and 0% in the placebo group.
During routine laboratory monitoring in the 12 week controlled phase, a decrease in neutrophil counts below 1 x 109/l occurred in 7% of patients in the tocilizumab group,
During routine laboratory monitoring in the tocilizumab all exposure population, elevation in total cholesterol>